TipRanks
Vaishali Pharma Ltd. (IN:VAISHALI)
:VAISHALI
India Market
Want to see IN:VAISHALI full AI Analyst Report?

Vaishali Pharma Ltd. (VAISHALI) Ratios

1 Followers

Vaishali Pharma Ltd. Ratios

IN:VAISHALI's free cash flow for Q1 2027 was ₹0.11. For the 2027 fiscal year, IN:VAISHALI's free cash flow was decreased by ₹ and operating cash flow was ₹0.06. See a summary of the company’s cash flow.
Ratios
TTM
Mar 26Mar 25Mar 24Mar 23
Liquidity Ratios
Current Ratio
0.00 2.34 2.61 2.25 2.27
Quick Ratio
0.00 2.27 2.49 2.24 2.17
Cash Ratio
0.00 0.03 0.05 0.04 0.02
Solvency Ratio
-0.07 0.09 0.03 0.03 0.19
Operating Cash Flow Ratio
0.00 0.00 -0.49 0.02 0.03
Short-Term Operating Cash Flow Coverage
0.00 0.00 -2.52 0.09 0.13
Net Current Asset Value
₹ 691.15M₹ 586.89M₹ 595.55M₹ 374.03M₹ 343.05M
Leverage Ratios
Debt-to-Assets Ratio
0.00 0.15 0.11 0.17 0.19
Debt-to-Equity Ratio
0.00 0.27 0.19 0.31 0.36
Debt-to-Capital Ratio
0.00 0.21 0.16 0.24 0.27
Long-Term Debt-to-Capital Ratio
0.00 0.08 0.06 0.08 0.11
Financial Leverage Ratio
0.00 1.79 1.69 1.87 1.95
Debt Service Coverage Ratio
2.06 0.19 0.31 0.26 0.85
Interest Coverage Ratio
1.99 1.79 -0.25 0.30 5.47
Debt to Market Cap
0.00 0.29 0.70 0.68 0.84
Interest Debt Per Share
0.14 1.60 9.60 12.39 15.21
Net Debt to EBITDA
0.00 4.24 3.25 3.80 1.25
Profitability Margins
Gross Profit Margin
9.21%9.32%10.39%11.18%18.54%
EBIT Margin
4.15%3.23%2.84%3.09%15.58%
EBITDA Margin
4.70%3.78%3.33%3.68%16.31%
Operating Profit Margin
3.37%3.23%-0.40%0.78%17.73%
Pretax Profit Margin
5.16%5.07%1.24%1.07%12.70%
Net Profit Margin
3.97%3.83%0.83%0.83%9.48%
Continuous Operations Profit Margin
3.95%3.83%0.83%0.83%9.48%
Net Income Per EBT
76.79%75.45%66.68%77.63%74.66%
EBT Per EBIT
153.21%157.09%-308.97%138.39%71.61%
Return on Assets (ROA)
0.00%3.38%0.74%0.90%8.37%
Return on Equity (ROE)
6.27%6.03%1.26%1.68%16.29%
Return on Capital Employed (ROCE)
0.00%4.68%-0.57%1.43%26.38%
Return on Invested Capital (ROIC)
0.00%3.00%-0.34%0.92%16.63%
Return on Tangible Assets
0.00%3.40%0.75%0.91%8.46%
Earnings Yield
4.14%6.56%4.79%3.90%40.51%
Efficiency Ratios
Receivables Turnover
0.00 2.14 2.12 1.39 1.06
Payables Turnover
0.00 4.66 3.27 3.84 3.04
Inventory Turnover
0.00 29.00 18.45 195.98 17.93
Fixed Asset Turnover
0.00 94.22 85.32 59.29 38.75
Asset Turnover
0.00 0.88 0.90 1.08 0.88
Working Capital Turnover Ratio
3.34 1.69 1.87 2.10 2.14
Cash Conversion Cycle
0.00 104.60 80.33 168.49 243.00
Days of Sales Outstanding
0.00 170.37 172.19 261.72 342.78
Days of Inventory Outstanding
0.00 12.58 19.78 1.86 20.36
Days of Payables Outstanding
0.00 78.36 111.65 95.10 120.14
Operating Cycle
0.00 182.96 191.98 263.59 363.14
Cash Flow Ratios
Operating Cash Flow Per Share
0.00 0.00 -13.20 0.63 0.97
Free Cash Flow Per Share
0.00 0.00 -13.41 0.21 0.70
CapEx Per Share
0.00 0.00 0.21 0.09 0.27
Free Cash Flow to Operating Cash Flow
0.00 0.00 1.02 0.34 0.72
Dividend Paid and CapEx Coverage Ratio
0.00 0.00 -63.79 7.27 3.63
Capital Expenditure Coverage Ratio
0.00 0.00 -63.79 7.27 3.63
Operating Cash Flow Coverage Ratio
0.00 0.00 -1.55 0.06 0.07
Operating Cash Flow to Sales Ratio
0.00 0.00 -0.20 <0.01 0.02
Free Cash Flow Yield
0.00%0.00%-115.78%1.47%4.80%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
23.23 15.25 20.68 25.63 2.47
Price-to-Sales (P/S) Ratio
0.79 0.58 0.17 0.21 0.23
Price-to-Book (P/B) Ratio
1.49 0.92 0.26 0.43 0.40
Price-to-Free Cash Flow (P/FCF) Ratio
0.00 0.00 -0.86 67.97 20.83
Price-to-Operating Cash Flow Ratio
0.00 0.00 -0.88 22.84 15.10
Price-to-Earnings Growth (PEG) Ratio
-0.04 -0.36 -2.14 -0.28 0.04
Enterprise Value Multiple
16.74 19.68 8.42 9.61 2.69
Enterprise Value
848.96M 809.73M 277.56M 304.62M 305.07M
EV to EBITDA
16.74 19.68 8.42 9.61 2.69
EV to Sales
0.79 0.74 0.28 0.35 0.44
EV to Free Cash Flow
0.00 0.00 -1.41 112.37 38.99
EV to Operating Cash Flow
0.00 0.00 -1.43 37.76 28.26
Tangible Book Value Per Share
5.30 5.25 43.47 33.05 35.51
Shareholders’ Equity Per Share
5.30 5.31 44.10 33.69 36.28
Tax and Other Ratios
Effective Tax Rate
0.24 0.25 0.33 0.22 0.25
Revenue Per Share
8.27 8.36 67.27 67.84 62.35
Net Income Per Share
0.33 0.32 0.56 0.57 5.91
Tax Burden
0.77 0.75 0.67 0.78 0.75
Interest Burden
1.24 1.57 0.44 0.35 0.81
Research & Development to Revenue
0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
0.06 0.06 0.11 <0.01 <0.01
Stock-Based Compensation to Revenue
0.00 0.00 0.00 0.00 0.00
Income Quality
0.00 0.00 -23.78 1.12 0.12
Currency in INR